Literature DB >> 18032589

A small dose of HIV? HIV vaccine mental models and risk communication.

Peter A Newman1, Danielle S Seiden, Kathleen J Roberts, Lisa Kakinami, Naihua Duan.   

Abstract

Existing knowledge and beliefs related to HIV vaccines provide an important basis for the development of risk communication messages to support future HIV vaccine dissemination. This study explored HIV vaccine mental models among adults from segments of the population disproportionately affected by HIV/AIDS. Nine focus groups were conducted with participants (N = 99; median age = 33 years; 48% female; 22% African American, 44% Latino, and 28% white) recruited from needle exchange sites, public clinics, and gay community centers in Los Angeles. Data were analyzed using narrative thematic analysis and Ethnograph qualitative software. Mental models of HIV vaccines included live virus, side effects, complete protection (100% efficacy, lifetime protection, reduced anxiety about HIV/AIDS), and "high-risk groups." HIV vaccine risk communication to counter undue fears of vaccine-induced infection and side effects and to mitigate exaggerated expectations of a "magic bullet" may be vital to the effectiveness of first-generation HIV vaccines in controlling the AIDS epidemic.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032589     DOI: 10.1177/1090198107305078

Source DB:  PubMed          Journal:  Health Educ Behav        ISSN: 1090-1981


  14 in total

1.  "Once Bitten, Twice Shy": participant perspectives in the aftermath of an early HIV vaccine trial termination.

Authors:  P A Newman; S Yim; A Daley; R Walisser; R Halpenny; W Cunningham; M Loutfy
Journal:  Vaccine       Date:  2010-11-12       Impact factor: 3.641

2.  Conceptual framework for behavioral and social science in HIV vaccine clinical research.

Authors:  Chuen-Yen Lau; Edith M Swann; Sagri Singh; Zuhayr Kafaar; Helen I Meissner; James P Stansbury
Journal:  Vaccine       Date:  2011-08-05       Impact factor: 3.641

3.  "Speaking the dialect": understanding public discourse in the aftermath of an HIV vaccine trial shutdown.

Authors:  Peter A Newman; Carmen Logie; Llana James; Tamicka Charles; John Maxwell; Khaled Salam; Michael Woodford
Journal:  Am J Public Health       Date:  2011-07-21       Impact factor: 9.308

4.  Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (LA VOICES).

Authors:  Peter A Newman; Sung-Jae Lee; Naihua Duan; Ellen Rudy; Terry K Nakazono; John Boscardin; Lisa Kakinami; Steven Shoptaw; Allison Diamant; William E Cunningham
Journal:  Health Serv Res       Date:  2009-09-24       Impact factor: 3.402

5.  Young men who have sex with men's awareness, acceptability, and willingness to participate in HIV vaccine trials: Results from a nationwide online pilot study.

Authors:  Daniel Connochie; Ryan C Tingler; José A Bauermeister
Journal:  Vaccine       Date:  2019-09-13       Impact factor: 3.641

6.  "If It's Not Working, Why Would They Be Testing It?": mental models of HIV vaccine trials and preventive misconception among men who have sex with men in India.

Authors:  Venkatesan Chakrapani; Peter A Newman; Neeti Singhal; Ruban Nelson; Murali Shunmugam
Journal:  BMC Public Health       Date:  2013-08-07       Impact factor: 3.295

7.  I'm positive, but i'm negative: Competing Voices in Informed Consent and Implications for HIV vaccine trials.

Authors:  Clinton Rautenbach; Graham Lindegger; Catherine Slack; Melissa Wallace; Peter Newman
Journal:  J Empir Res Hum Res Ethics       Date:  2015-04       Impact factor: 1.742

8.  Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India: a social ecological approach.

Authors:  Venkatesan Chakrapani; Peter A Newman; Neeti Singhal; Jhalak Jerajani; Murali Shunmugam
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

9.  HIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study.

Authors:  April M Young; Ralph J DiClemente; Daniel S Halgin; Claire E Sterk; Jennifer R Havens
Journal:  BMC Public Health       Date:  2014-05-30       Impact factor: 3.295

10.  Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study.

Authors:  Jill A Fisher; Lisa McManus; Marci D Cottingham; Julianne M Kalbaugh; Megan M Wood; Torin Monahan; Rebecca L Walker
Journal:  PLoS Med       Date:  2018-11-20       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.